Wishing to die or self-harm after stroke: A planned secondary analysis of the AFFINITY Randomised Controlled Trial

Almeida, Osvaldo P., Hankey, Graeme J., Ford, Andrew, Etherton-Beer, Christopher, Flicker, Leon and Hackett, Maree orcid iconORCID: 0000-0003-1211-9087 (2022) Wishing to die or self-harm after stroke: A planned secondary analysis of the AFFINITY Randomised Controlled Trial. Maturitas, 166 . pp. 86-88. ISSN 0378-5122

[thumbnail of AAM]
Preview
PDF (AAM) - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

922kB

Official URL: https://doi.org/10.1016/j.maturitas.2022.08.011

Abstract

We investigated the cumulative prevalence of self-harm ideation among stroke survivors of the AFFINITY trial. We assessed these thoughts with the last item of the PHQ-9, and functional impairment with the modified Rankin Scale (mRS). Of 1221 participants (age 63.9 ± 12.3 years, 775 men), 11 reported wishing to die or self-harm at baseline. By week 52, 36 of 1159 surviving participants had reported wishing to die or self-harm. Treatment with fluoxetine for 26 weeks did not change the prevalence of these thoughts compared with placebo. Clinically significant symptoms of depression were present in 95 % of participants with recurrent self-harm thoughts.
The study was registered with the Australian and New Zealand Clinical Trials Registry, ACTRN12611000774921.


Repository Staff Only: item control page